JESSICA ARP: Open Payments
NPI 1912241183 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 18 payments from 8 companies in 2025. Trend: 2023 $376 · 2024 $393 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $122 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $85 |
| Octapharma USA, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $39 |
| Biogen, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Veozah, FIBRYGA, ZURZUVAE, Wegovy, COMIRNATY, JOURNAVX, NURTEC ODT, Lynkuet.
Industry payments across IA — which companies pay providers there.
